Stifel reiterates Buy rating on Arrowhead Pharma stock at $104
Stifel reiterates Buy rating on Arrowhead Pharma stock at $104
Profit by knowlytics
Uncover the latest corporate headlines, economic policies, macro-level market updates, and industry developments shaping Indian and global markets on FinSiddhi.
Stifel reiterates Buy rating on Arrowhead Pharma stock at $104
Stifel holds BioMarin stock rating, keeps $70 target on IP deal
Nasdaq 100 coiled in tight rectangle at 29,407: Hourly
Zoomd Q2 2026 slides: profit rebound offsets revenue shortfall
Under the new fee structure, subscribers registering for NPS through a PoP will be charged a one-time onboarding fee of Rs 200 for each Permanent Retirement Account Number (PRAN). However, the entire Rs 200 will not be taken from the subscriber’s account at once.
Nvidia revives Rubin CPX chip program with 2027 launch planned, analyst says
Oil boom drives fastest Nigerian growth in five years
NGL Energy Partners LP stock hits 52-week high at 18.8 USD
OpenClaw has unveiled its most comprehensive software upgrade yet with the arrival of version 2.0. This update enhances user accessibility significantly and integrates features for multi-user collaboration. Installation has been streamlined, along with expanded cross-platform automation tools. The redesigned browser interface provides a centralized workspace that improves navigation, while sophisticated routines and enhanced information retrieval…
After years of erosion and extreme weather, Dickinson Bay’s lost islands have seen a remarkable revival. Spearheaded by the Galveston Bay Foundation and U.S. Fish and Wildlife Service, habitat restoration efforts have successfully created new nesting habitats for over 2,500 pairs of waterbirds. This revitalization not only boosts local biodiversity but also creates job opportunities…